BioStem Technologies, Inc.

BSEM · XNAS

CIK 1658678fmd_18FV2316A8BN7PCHEN39F9R4MMManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 4 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.